SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1558Peter I know the feeling hitting me head when this one hit 8 telling meself it dalroi-7/25/2003
1557Don't know anything about the akys product, but attempts at a home/mobile dikeokalani'nui-7/25/2003
1556Some question as to whether Roche/Igen belongs here or not. On the surface itBiomaven-7/25/2003
1555<i>I know nada about AKSY.</i> I follow them - been cursing some upBiomaven-7/25/2003
1554That's a neat trick - buying almost 2/3 of a company's outstanding stocktom pope-7/25/2003
1553I know nada about AKSY. It seems Nigel has gone on holiday without permission atuck-7/25/2003
1552any comments on this one ? seems to be a forced munch candidate ? cheers Stefadalroi-7/25/2003
1551Stratagene, a well thought of trickle company, merges and goes public with Hycortuck-7/24/2003
1550Johnson & Johnson's Weldon May Buy Rivals as Cypher Loses Edge July 14 Icebrg-7/14/2003
1549Merck CEO Says Co Ruled Out Acquiring Schering-Plough -FT Tuesday July 8, 6:13 pkeokalani'nui-7/8/2003
1548Ribopharma, Alnylam Plan to Unveil Merger By GAUTAM NAIK Staff Reporter of THEDoc Bones-7/7/2003
1547>>Vernalis is pretty desperate for cash. This will stop them having to selIcebrg-7/3/2003
1546<i> I clearly cannot see what advantages...</i> Vernalis is pretty nigel bates-7/3/2003
1545Brit Biotech to buy drugs rival Vernalis Thursday July 3, 2:46 am ET [British BIcebrg-7/3/2003
1544Abgenix shares rise on talk of Amgen interest Wednesday July 2, 6:15 pm ET LOSBiomaven-7/2/2003
1543Some speculation over on the Valuation thread about AMGN/TLRK: Message 19066160Biomaven-6/27/2003
1542If so, this news published by semi bull on the MLNM site might make them even tatom pope-6/25/2003
1541From Briefing.com... * 14:48 ET MLNM intraday spike attributed to AMGN takeoverIan@SI-6/25/2003
1540Just a quick note.... Joe Kernan at CNBC was all over the 50.5% issue from hisscaram(o)uche-6/24/2003
1539Interesting. That then also means there will be almost no takeover premium for keokalani'nui-6/24/2003
1538<i>Other would-be bidders for Idec may be dissuaded by the fact that GenenBiomaven-6/24/2003
1537Biotech Companies Agree to Merge in $6.79 Billion Deal [NYT] By ANDREW POLLACK Doc Bones-6/24/2003
1536Idec Pharmaceuticals, Biogen To Merge in $6.4 Billion Deal By DAVID ARMSTRONG, Doc Bones-6/24/2003
1535They both open up between 3% and 4%, so I guess the market moderately approves, Biomaven-6/23/2003
1534It is a bit strange - Yahoo gives a market cap of 6.5 for BGEN and 6.04 for IDPHtom pope-6/23/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News